Parallel Cell Processing Method and Facility
Global Life Sciences Solutions USA LLC
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 4 of these applications claim priority to application PCT/EP2015/066666, filed Jul 21, 2015. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,184,949 | Parallel Cell Processing Method and Facility In force · High confidence UsedRemaining | Global Life Sciences Solutions USA LLC | In force | High confidence | ||
| US 10,877,055 | Parallel Cell Processing Method and Facility In force · High confidence | Global Life Sciences Solutions USA LLC | In force | High confidence | ||
| US 11,879,903 | Parallel Cell Processing Method and Facility In force · High confidence | Global Life Sciences Solutions USA LLC | In force | High confidence | ||
| US 12,571,812 | Parallel Cell Processing Method and Facility In force · High confidence | Global Life Sciences Solutions USA LLC | In force | High confidence | ||
| Application 19/334,565 | Parallel Cell Processing Method and Facility Pending Not granted | Global Life Sciences Solutions USA LLC | Pending | Not granted |
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Global Life Sciences Solutions USA LLC.
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.